45 East 45th Street,

New York,

NY,

USA,

ZIP: 10017

Phone: 646 350 2580

Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R and D, addressing aspects from all facets of IO including:
Discovery/Preclinical Science
Translational Science
Clinical Development
Business Aspects
Investor Relations
Emerging Technologies
Biomarkers / Diagnostics
Trends in the Field

Lead Advisors Dr Axel Hoos, GSK, and Dr James Gulley, NCI, developed the 4th annual IO360° program to include 45 speakers and over 30 talks. Dr Andrew Baum is the investor relations plenary keynote.

IO360° provides the most up-to-date research, data and progress to help IO stakeholders:
Be at the forefront of relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof​
Receive the latest pre-clinical, translational and clinical data from academic and industry
Gain a greater understanding of what assets are available for potential combinations  
Create and prioritize strategies targeted toward specific tumor types​
Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
Get key investor and analyst evaluations and insights on the IO landscape, challenges and what’s next
Hear reports on industry trends from Endpoint News and BioCentury Innovations and a progress update on the Cancer Moonshot
Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
Obtain coverage on a wide range of emerging technologies

Pharma and Biotech Special Rate:
To support IO teams in drug development, the registration fee for pharma and biotech companies includes a guest pass for a colleague from within the same company who has not yet attended IO360°. Guest pass must be claimed by Nov. 3, 2021.

Email [email protected] for sponsorship and exhibitor opportunities.

URL:
Website: https://go.evvnt.com/149446-1

Prices:
Pharma and Biotech starting rate: USD 1895,
Standard Industry starting rate: USD 1895,
Academia, Non-Profit and Government starting rate: USD 947.50.

James Gulley MD PhD, Axel Hoos MD PhD, Andrew Baum MD, Roy Baynes MD PhD, Ali Behbahani MD MBA, Jeff Bockman PhD, Bruce Booth DPhil, Lisa Butterfield PhD, Dario Campana MD PhD, John D Carroll, Jasmine Ferrer DPhil, Simone Fishburn PhD, Simeon George MD, William Grossman MD PhD, Laura Johnson PhD, Lanny Kirsch MD, Ron Korn MD PhD, Corey Langer MD FACP, Patrick Mayes PhD, Ian McCaffery PhD, Adam Millinger, Naiyer Rizvi MD, Greg Simon JD, Julius Strauss MD, Hiroomi Tada MD PhD, Jonathan Wan, Jeffrey Weber MD PhD, Cissy Young PhD MBA.

HEALTH AND MEDICINE CONFERENCES